EUVIMEDEUVIMED entdecken
Crossref

miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4

Huawei Jiang, Zhiwei Su, Wangxiong Hu, Xianggui Yuan, Teng Yu, Jing Yang, Xibin Xiao, Shu Zheng, Biaoyang Lin iD

OMICS: A Journal of Integrative Biology · 2023

DOI: 10.1089/omi.2023.0046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OMICS: A Journal of Integrative Biology, 2023. Verfasst von Huawei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology (Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laborator…. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicroRNAsGliomaBrain NeoplasmsHumansAnimalsMiceProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesCell Line, TumorSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticCell MovementReceptor, ErbB-4

Stichwörter der Autor:innen

ERBB4PI3K/Akt signaling pathwaycancer researchdrug targetsglioblastomamiR-433

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMicroRNAsERBB4 protein, humanReceptor, ErbB-4MIRN433 microRNA, humanErbb4 protein, mouse

Autor:innen und Institutionen

  • Department of Hematology (Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences), The Second Affiliated Hos…
  • Department of Medical Oncology, Zhejiang Hospital, Hangzhou, China.
  • Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang-California International Nanosystems Institute (ZCNI) Proprium Research Center, Zhejiang University, Hangzhou, China.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA.

ORCID-Profile: Biaoyang Lin

Zitieren

APA

Jiang, H., Su, Z., Hu, W., Yuan, X., Yu, T., Yang, J., Xiao, X., Zheng, S., & Lin, B. (2023). miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2023.0046

Vancouver

Jiang H, Su Z, Hu W, Yuan X, Yu T, Yang J, et al. miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4. OMICS: A Journal of Integrative Biology. 2023. doi:10.1089/omi.2023.0046

BibTeX
@article{Jiang2023,
  author = {Jiang, Huawei and Su, Zhiwei and Hu, Wangxiong and Yuan, Xianggui and Yu, Teng and Yang, Jing and Xiao, Xibin and Zheng, Shu and Lin, Biaoyang},
  title = {miR-433 Inhibits Glioblastoma Progression by Suppressing the PI3K/Akt Signaling Pathway Through Direct Targeting of ERBB4},
  journal = {OMICS: A Journal of Integrative Biology},
  year = {2023},
  doi = {10.1089/omi.2023.0046}
}
Kostenlos starten →